R-Biopharm AG - Comment

Document ID: FDA-2010-D-0565-0005
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 25 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 31 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: November 29 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: February 28 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80bd1d8d
View Document:

This is comment on Notice

Same comment as Tracking Number 80bd1d8c but as a pdf-file (easier to read).

Title:
R-Biopharm AG - Comment

View Attachment:

Total: 4

ATCC - Comment
Public Submission Posted: 01/03/2011 ID: FDA-2010-D-0565-0003

Comment Period Closed
Feb 28,2011 11:59 PM ET

R-Biopharm AG - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0565-0004

Comment Period Closed
Feb 28,2011 11:59 PM ET

R-Biopharm AG - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0565-0005

Comment Period Closed
Feb 28,2011 11:59 PM ET

Association for Molecular Pathology (AMP) - Comment
Public Submission Posted: 03/03/2011 ID: FDA-2010-D-0565-0006

Comment Period Closed
Feb 28,2011 11:59 PM ET